OmegaMore
Biotech Products for Chronic Cognitive Diseases
Company Overview
Snapshot
Founded in January 2013 by Israel Galmor, OmegaMore operates with 1-10 employees. The company has secured funding across one round, with ExitValley participating. OmegaMore develops, manufactures, and markets omega-3 supplements extracted from sea algae, focusing on formulations for cognitive and cardiovascular health.
Business overview
OmegaMore is a biotechnology company specializing in the development, manufacturing, and marketing of omega-3 supplements derived from sea algae. The company's core technology involves cultivating algae in freshwater ponds to produce formulations designed to treat and prevent cognitive diseases such as Alzheimer's, depression, and ADHD, as well as heart and liver malfunctions and metastatic cancer. OmegaMore serves the health and life sciences market, targeting consumers interested in pharmaceutical-grade supplements for brain and cardiovascular health.
Log in to access full profile ›Company Intelligence Q&A
- What is OmegaMore's primary focus?
- OmegaMore develops, manufactures, and markets omega-3 supplements extracted from sea algae, focusing on formulations for the treatment and prevention of cognitive diseases, heart and liver malfunctions, and metastatic cancer.
- Who founded OmegaMore?
- OmegaMore was founded by Israel Galmor in January 2013.
- What is OmegaMore's mission?
- OmegaMore's mission is to improve quality of life by preventing and blocking the development of most brain disorders and cardiovascular diseases, and alleviating existing illnesses by increasing the concentration of omega-3 fatty acids in red blood cells.
- How does OmegaMore cultivate its algae?
- OmegaMore cultivates its algae in freshwater ponds where salts and minerals are added, simulating the natural environment of algae without exposure to pollution or heavy metals.